Changes

Postmortem Chemotherapy

438 bytes added, 18:26, 28 January 2017
no edit summary
'''Patient Selection for Postmortem Chemotherapy'''
----
Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status but are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”]</ref> Patients usually must undergo [[Transthoracic Echocardiogram|transthoracic echocardiogram]] (or [[Amazon Echocardiogram|TTE]]) in order to avoid cardiotoxicity as is the case with doxorubin for example.  '''Monitoring During Chemotherapy'''----Typically, decreased patients are given '''postmortem chemotherapy''' in the outpatient setting where skilled health care professionals look for the presence of [[Vital Signs|vital signs]].